prabotulinumtoxinA — IND submission
in Q4'26
IND submission planned in Q4'26 for CMAP pharmacodynamic study; study initiation expected in Q1'27Source filing
AEON biotech catalysts & pipeline
AEON BIOPHARMA INC · Data as of 2026-10-25
catalyst calendar
/